Company: TBPH
Filing Date: 2025-05-08
Form Type: 8-K
Source: 0001104659-25-046137
Chunk: 0

Company: Theravance Biopharma, Inc.
Filing Date: 2025-05-08
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial
Condition.

On May 8, 2025, Theravance Biopharma, Inc. (the “ Company”)
issued a press release and is holding a conference call regarding its financial results for the quarter ended March 31, 2025 and a business
update. A copy of the press release is furnished as Exhibit 99.1 to this Current Report and a copy of materials that will accompany the
call is furnished as Exhibit 99.2 to this Current Report.

The information in Item 2.02 and in Item 9.01 of this Current Report
on Form 8-K, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for the purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the “ Securities Exchange Act of 1934”), or otherwise subject to the
liabilities of that Section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or
the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.